Thalidomide-Dexamethasone for Multiple Myeloma

Completed · Phase 2/Phase 3

Conditions studied: Multiple Myeloma

In brief

Objective is to assess the activity of the combination of thalidomide and dexamethasone in patients with previously untreated multiple myeloma.

Key facts

Study ID

NCT00038090

Run by

M.D. Anderson Cancer Center

People needed

83

Starts

2000-06-01

Expected to finish

2005-05-01

Last updated by the study team

2018-10-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.